J&J to buy cancer drug technology developer Firefly Bio for $1 billion

J&J to buy cancer drug technology developer Firefly Bio for $1 billion  Reuters

Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.